Trials / Completed
CompletedNCT03224260
To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants
Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Access the safety, tolerability, and pharmacokinetics of BMS-986177 in healthy Japanese participants after multiple doses are administered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986177 | Oral Suspension |
| OTHER | Matched Placebo | Oral Suspension |
Timeline
- Start date
- 2017-06-28
- Primary completion
- 2017-11-07
- Completion
- 2017-11-07
- First posted
- 2017-07-21
- Last updated
- 2018-06-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03224260. Inclusion in this directory is not an endorsement.